AUS
NZ
UK
CA
USA
IND
Health
Is ResMed (ASX:RMD) Undervalued in 2025? | All Ordinaries Healthcare Stock with Global Tech Focus
July 27, 2025 07:28 PM AEST| By Team Kalkine MediaHighlights,Global healthcare firm with strong presence in sleep and respiratory care,Combines smart hardware with SaaS-driven efficiency,Financially robust with a conservative debt profile,ResMed (RMD) is a globally recognised medical technology comp...
ASX 200 Futures Watch: Clarity Pharmaceuticals (ASX:CU6) Surges Amid Anticipated Clinical Milestone
July 27, 2025 06:21 PM AEST| By Team Kalkine MediaHighlights:,Clarity Pharmaceuticals gains momentum on the ASX,Clinical trial developments boost investor sentiment,Market attention shifts to Co-PSMA study results,ASX 200 futures,edged higher on Thursday, buoyed by strong interest in biotech counter...
Telix Pharmaceuticals (ASX:TLX) Share Slide | R&D Strategy and Revenue Guidance in ASX 200 Biotech
July 27, 2025 06:06 PM AEST| By Team Kalkine MediaHighlights,Telix reaffirms revenue guidance despite recent share movement,Rising R&D marks shift toward innovation,Illuccix and RLS remain key revenue contributors,Telix Pharmaceuticals (TLX), a key biotechnology company listed on the,ASX 200,, exper...
Has Oneview Healthcare (ASX:ONE) Moved Ahead of Its Fundamentals?
July 26, 2025 04:57 PM AEST| By Team Kalkine MediaHighlights,Revenue growth has lagged behind other healthcare service peers,Recent share momentum may not reflect underlying business pace,Caution warranted if financials don’t align with current market sentiment,Oneview Healthcare (ASX:ONE) has exper...
CSL vs Pro Medicus: Exploring Healthcare Picks from ASX 200 in 2025
July 26, 2025 02:21 PM AEST| By Team Kalkine MediaHighlights,CSL and Pro Medicus operate in distinct segments of healthcare,CSL's strengths lie in mature pharma and biotech infrastructure,Pro Medicus is known for radiology-focused software solutions,When it comes to healthcare-focused,ASX 200,stocks...
Race Oncology’s RC220 Marks Clinical Advancement in ASX Biotech Landscape
July 25, 2025 05:23 PM AEST| By Team Kalkine MediaHighlights,First clinical trial dosing of RC220 completed,Broader application explored beyond leukemias,New leadership appointments reinforce trial execution,Race Oncology Ltd (ASX:RAC) has initiated clinical dosing of its novel compound RC220, a ref...
Althea Group Holdings (ASX:AGH) Ushers in New Leadership to Strengthen Beverage Strategy
July 24, 2025 07:42 PM AEST| By Team Kalkine MediaHighlights,Leadership change announced at Althea Group Holdings,New interim head appointed with beverage industry background,Focus sharpened on expanding THC beverage segment,Althea Group Holdings (ASX:AGH), a company operating within the medicinal c...
CSL Ltd: Exploring One of the ASX 200 Healthcare Giants
July 24, 2025 06:16 PM AEST| By Team Kalkine MediaHighlights,CSL Ltd maintains strong financial fundamentals,Operates across global biopharma, flu vaccines, and kidney care,Continues to draw long-term attention among ASX 200 stocks,CSL Ltd (ASX:CSL) remains a prominent name among,ASX 200,stocks, kno...
Prescient Therapeutics Advances Cancer Drug PTX-100 Toward Next Clinical Milestone
July 24, 2025 05:41 PM AEST| By Team Kalkine MediaHighlights,PTX-100 enters Phase 2 trials targeting hard-to-treat T-cell lymphoma,Regulatory designations boost development prospects,Multiple commercialisation routes under consideration,Prescient Therapeutics (ASX:PTX) is making steady progress in i...
Prescient Therapeutics Advances PTX-100 Cancer Therapy Toward Market Readiness
July 24, 2025 10:13 AM AEST| By Team Kalkine MediaHighlights,PTX-100 progressing through Phase 2 trials,Focused on addressing rare, aggressive cancer type,Gains regulatory support for faster market access,Prescient Therapeutics (ASX:PTX) is advancing its lead therapy candidate PTX-100 through Phase...
Cochlear (ASX:COH) Growth Story: Financial Strength, Performance, and ASX 300 Presence
July 23, 2025 06:57 PM AEST| By Team Kalkine MediaHighlights,Cochlear (COH) showcases consistent revenue momentum,Trends reflect operational resilience,Strong balance sheet underscores capital stability,Cochlear (COH), a Sydney-based medical device company, continues to gain traction within the hear...
NeuroScientific Eyes Stem Cell Breakthroughs in Chronic Disease Research
July 23, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,NeuroScientific explores stem cell use for chronic conditions,Ongoing clinical trials target Crohn’s and GVHD,StemSmart therapy shows encouraging initial outcomes,NeuroScientific Biopharmaceuticals (ASX:NSB) is advancing its therapeutic pi...
Race Oncology (ASX:RAC) Advances RC220 Trial, Boosts Medical Team Strength
July 23, 2025 03:56 PM AEST| By Team Kalkine MediaHighlights,RC220 trial progresses with first patient successfully treated,New medical leadership team appointed,Clinical expansion extends into Hong Kong,Race Oncology (ASX:RAC) has reported substantial strides in its RC220 Phase 1 clinical trial dur...
Pro Medicus (ASX:PME) Growth Journey: Healthcare Software Leader in the ASX 100 Landscape
July 23, 2025 03:51 PM AEST| By Team Kalkine MediaHighlights,PME develops software critical to radiology efficiency,Focused presence in global healthcare technology space,Positioned within the ASX 100 with SaaS-based momentum,Pro Medicus (PME), a constituent of the,ASX 100,, is a key player in the g...
Telix Faces Regulatory Inquiry: Clinical Pipeline in Focus Amid SEC Subpoena
July 23, 2025 02:59 PM AEST| By Team Kalkine MediaHighlights,Telix responds to US regulatory request,Clinical programs continue undisrupted,Commercial portfolio remains unaffected,Telix Pharmaceuticals (ASX:TLX), a biopharmaceutical company listed among the,ASX100 companies,, recently disclosed a re...
Enhancing Radiotherapy for Cancer: New Insights from Percheron Therapeutics (ASX:PER)
July 23, 2025 10:49 AM AEST| By Team Kalkine MediaHighlights,New antibody shows benefits when used with radiotherapy,Immune suppression target VISTA linked to treatment resistance,Early-stage results support advancement into clinical trials,Preclinical research from Stanford University has spotlight...
Clinuvel Pharmaceuticals (ASX:CUV): Earnings Strength vs Valuation in Allords
July 23, 2025 12:31 AM AEST| By Team Kalkine MediaHighlights,Clinuvel’s earnings growth outpaces many peers,Lower P/E ratio raises questions on market expectations,Company’s position within Allords adds broader visibility,Clinuvel Pharmaceuticals (ASX:CUV), a biotech company listed on the Australian...
Is Sonic Healthcare (ASX:SHL) Positioned for Long-Term Strength in 2025? | Key ASX 300 Metrics Explored
July 22, 2025 11:12 PM AEST| By Team Kalkine MediaHighlights,Sonic Healthcare operates across multiple global regions,Recent financial trends show shifting revenue and patterns,Debt position reveals capital structure and tolerance,Sonic Healthcare (SHL), a prominent name in the global medical diagno...
Insider Activity Raises Eyebrows at Sigma Healthcare (ASX:SIG) | ASX 300 Pharma Stock in Focus
July 22, 2025 08:01 PM AEST| By Team Kalkine MediaHighlights,Significant insider share exits over the past year,No insider activity reported,closely watching insider sentiment shift,Over the past year, insider transactions at Sigma Healthcare (SIG) have drawn attention, particularly due to several h...
Mach7 Technologies (ASX:M7T) Trades at a Discount Despite Steady Business Momentum
July 22, 2025 06:43 PM AEST| By Team Kalkine MediaHighlights,Valuation remains lower than healthcare industry peers,Revenue growth stable but below sector averages,Market signals caution on future outlook,Mach7 Technologies (ASX:M7T), a healthcare technology provider, is currently trading at a price...
Advertise your brand on Kalkine Media